Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.18 USD | +1.17% | +5.38% | -41.63% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.63% | 385M | |
+9.02% | 114B | |
+11.42% | 104B | |
-12.38% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.72% | 17.89B | |
+8.07% | 14.28B | |
+35.06% | 12.55B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Morgan Stanley Adjusts Talaris Therapeutics Price Target to $21 From $20, Maintains Overweight Rating